CLOSE
Public Domain, Wikimedia Commons
Public Domain, Wikimedia Commons

Wilder Penfield: The Pioneering Brain Surgeon Who Operated on Conscious Patients

Public Domain, Wikimedia Commons
Public Domain, Wikimedia Commons

For centuries, epilepsy was a source of mystery to scientists. Seizures were thought to be caused by everything from masturbation to demonic possession, and it wasn’t until the 1930s that a neurosurgeon showed the condition could sometimes be boiled down to specific spots in the brain. To do it, he had to open up patients’ heads and electrocute their brain tissue—while they were still conscious.

Wilder Penfield, the subject of today’s Google Doodle, was born on January 26, 1891 in Spokane, Washington. According to Vox, the Canadian-American doctor revolutionized the way we think about and treat epilepsy when he pioneered the Montreal Procedure. The operation required him to remove portions of the skulls of epilepsy sufferers to access their brains. He believed seizures were connected to small areas of brain tissue that were somehow damaged, and by removing the affected regions he could cure the epilepsy. His theory was based on the fact that people with epilepsy often experience “auras” before a seizure: vivid recollections of random scents, tastes, or thoughts.

To pinpoint the damaged brain tissue, he would have to locate the part of the brain tied to his patient’s aura. This meant that the patient would need to be awake to tell him when he struck upon the right sensation. Penfield stimulated the exposed brain tissue with an electrode, causing the patient to either feel numbness in certain limbs, experience certain smells, or recall certain memories depending on what part of the brain he touched. A local anesthetic reduced pain in the head; shocking the brain didn’t cause any pain because the organ doesn’t contain pain receptors.

During one of his surgeries, a patient famously cried, “I smell burnt toast!” That was the same scent that visited her before each seizure, and after Penfield removed the part of her brain associated with the sensation, her epilepsy went away.

Brain surgery isn’t a cure-all for every type of epilepsy, but treatments similar to the one Penfield developed are still used today. In some cases, as much as half of the brain is removed with positive results.

[h/t Vox]

nextArticle.image_alt|e
iStock
arrow
Medicine
New Cancer-Fighting Nanobots Can Track Down Tumors and Cut Off Their Blood Supply
iStock
iStock

Scientists have developed a new way to cut off the blood flow to cancerous tumors, causing them to eventually shrivel up and die. As Business Insider reports, the new treatment uses a design inspired by origami to infiltrate crucial blood vessels while leaving the rest of the body unharmed.

A team of molecular chemists from Arizona State University and the Chinese Academy of Sciences describe their method in the journal Nature Biotechnology. First, they constructed robots that are 1000 times smaller than a human hair from strands of DNA. These tiny devices contain enzymes called thrombin that encourage blood clotting, and they're rolled up tightly enough to keep the substance contained.

Next, researchers injected the robots into the bloodstreams of mice and small pigs sick with different types of cancer. The DNA sought the tumor in the body while leaving healthy cells alone. The robot knew when it reached the tumor and responded by unfurling and releasing the thrombin into the blood vessel that fed it. A clot started to form, eventually blocking off the tumor's blood supply and causing the cancerous tissues to die.

The treatment has been tested on dozen of animals with breast, lung, skin, and ovarian cancers. In mice, the average life expectancy doubled, and in three of the skin cancer cases tumors regressed completely.

Researchers are optimistic about the therapy's effectiveness on cancers throughout the body. There's not much variation between the blood vessels that supply tumors, whether they're in an ovary in or a prostate. So if triggering a blood clot causes one type of tumor to waste away, the same method holds promise for other cancers.

But before the scientists think too far ahead, they'll need to test the treatments on human patients. Nanobots have been an appealing cancer-fighting option to researchers for years. If effective, the machines can target cancer at the microscopic level without causing harm to healthy cells. But if something goes wrong, the bots could end up attacking the wrong tissue and leave the patient worse off. Study co-author Hao Yan believes this latest method may be the one that gets it right. He said in a statement, "I think we are much closer to real, practical medical applications of the technology."

[h/t Business Insider]

nextArticle.image_alt|e
iStock
arrow
Medicine
New Peanut Allergy Patch Could Be Coming to Pharmacies This Year
iStock
iStock

About 6 million people in the U.S. and Europe have severe peanut allergies, including more than 2 million children. Now, French biotechnology company DBV Technologies SA has secured an FDA review for its peanut allergy patch, Bloomberg reports.

If approved, the company aims to start selling the Viaskin patch to children afflicted with peanut allergies in the second half of 2018. The FDA's decision comes in spite of the patch's disappointing study results last year, which found the product to be less effective than DBV hoped (though it did receive high marks for safety). The FDA has also granted Viaskin breakthrough-therapy and fast-track designations, which means a faster review process.

DBV's potentially life-saving product is a small disc that is placed on the arm or between the shoulder blades. It works like a vaccine, exposing the wearer's immune system to micro-doses of peanut protein to increase tolerance. It's intended to reduce the chances of having a severe allergic reaction to accidental exposure.

The patch might have competition: Aimmune Therapeutics Inc., which specializes in food allergy treatments, and the drug company Regeneron Pharmaceuticals Inc. are working together to develop a cure for peanut allergies.

[h/t Bloomberg]

SECTIONS

arrow
LIVE SMARTER
More from mental floss studios